placeholder image
R. S. Go All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants. 
    Leukemia. 2025
  • PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms. 
    Leukemia and Lymphoma. 2025
  • BCR-ABL testing in the evaluation of neutrophilia. 
    American Journal of Hematology. 2024
  • Personalized medicine in histiocytic disorders: novel targets in patients without MAPK alterations. 
    JCO precision oncology. 2024
    • Contact
    full name
  • R. S. Go
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration